Related Experiment Video

Updated: Jun 11, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Proteasome inhibitors prevent caspase-1-mediated disease in rodents challenged with anthrax lethal toxin

Stefan M Muehlbauer1, Heriberto Lima, David L Goldman

  • 1Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY 10461, USA.

The American Journal of Pathology
|July 3, 2010
PubMed

Insights

Pharmacological inhibition of caspase-1 (an innate immunity component) prevents anthrax lethal toxin-induced disease. Blocking caspase-1 activation is a potential therapeutic strategy for inflammatory diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • NOD-like receptors (NLRs) and caspase-1 are key in innate immunity.
  • Overactive NLRs and caspase-1 contribute to inflammatory diseases like anthrax.
  • Bacillus anthracis lethal toxin (LT) activates NLRs and caspase-1, causing anthrax symptoms.

Purpose of the Study:

  • To investigate if pharmacological inhibition of caspase-1 can prevent LT-mediated anthrax disease.
  • To evaluate the therapeutic potential of caspase-1 inhibitors against LT toxicity.

Main Methods:

  • Utilized caspase-1 and proteasome inhibitors in rat and mouse models.
  • Assessed LT-induced caspase-1 activation, cytolysis, disease progression, and survival rates.
  • Compared responses in LT-sensitive and LT-resistant rodent macrophages.

Main Results:

  • Caspase-1 and proteasome inhibitors blocked LT-induced caspase-1 activation and macrophage death.
  • The proteasome inhibitor NPI-0052 reduced disease progression and mortality in Fischer rats and BALB/c mice.
  • Lewis rats with LT-resistant macrophages showed no caspase-1 activation or rapid disease progression.

Conclusions:

  • Caspase-1 activation is essential for rapid disease progression following LT challenge in rodents.
  • Pharmacological inhibition of NLR signaling and caspase-1 presents a viable treatment strategy for inflammatory diseases.

More Related Videos

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling08:51

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling

Published on: June 25, 2015

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Inhalation Anthrax01:25

Inhalation Anthrax

Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...